North America, Europe, and Japan have 1 billion people; the rest of the world has 6 billion people. If 1/3 of the people in the rest of the world become pharmaceutical customers (which is very doable—see #msg-66835915, #msg-51490876), that’s twice as many new customers as the “traditional” market for Big Pharma.
Paraphrased from Chris Viehbacher’s presentation at SNY’s Investor Day today.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”